222 related articles for article (PubMed ID: 28131001)
1. Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP
Rajic Z; Tovmasyan A; de Santana OL; Peixoto IN; Spasojevic I; do Monte SA; Ventura E; Rebouças JS; Batinic-Haberle I
J Inorg Biochem; 2017 Apr; 169():50-60. PubMed ID: 28131001
[TBL] [Abstract][Full Text] [Related]
2. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
[TBL] [Abstract][Full Text] [Related]
3. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
[TBL] [Abstract][Full Text] [Related]
4. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
[TBL] [Abstract][Full Text] [Related]
5. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
Rebouças JS; Spasojević I; Batinić-Haberle I
J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
[TBL] [Abstract][Full Text] [Related]
6. Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+.
Spasojevic I; Batinic-Haberle I; Reboucas JS; Idemori YM; Fridovich I
J Biol Chem; 2003 Feb; 278(9):6831-7. PubMed ID: 12475974
[TBL] [Abstract][Full Text] [Related]
7. Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.
Rebouças JS; DeFreitas-Silva G; Spasojević I; Idemori YM; Benov L; Batinić-Haberle I
Free Radic Biol Med; 2008 Jul; 45(2):201-10. PubMed ID: 18457677
[TBL] [Abstract][Full Text] [Related]
8. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
[TBL] [Abstract][Full Text] [Related]
9. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
[TBL] [Abstract][Full Text] [Related]
10. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.
Tovmasyan A; Weitner T; Sheng H; Lu M; Rajic Z; Warner DS; Spasojevic I; Reboucas JS; Benov L; Batinic-Haberle I
Inorg Chem; 2013 May; 52(10):5677-91. PubMed ID: 23646875
[TBL] [Abstract][Full Text] [Related]
11. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
12. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
[TBL] [Abstract][Full Text] [Related]
13. Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.
Batinic-Haberle I; Tovmasyan A; Spasojevic I
Antioxid Redox Signal; 2018 Dec; 29(16):1691-1724. PubMed ID: 29926755
[TBL] [Abstract][Full Text] [Related]
14. Ortho Isomeric Mn(III) N-Alkyl- and Alkoxyalkylpyridylporphyrins-Enhancers of Hyaluronan Degradation Induced by Ascorbate and Cupric Ions.
Valachová K; Rapta P; Moura NMM; Batinic-Haberle I; Šoltés L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445313
[TBL] [Abstract][Full Text] [Related]
15. New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme.
Batinić-Haberle I; Spasojević I; Stevens RD; Bondurant B; Okado-Matsumoto A; Fridovich I; Vujasković Z; Dewhirst MW
Dalton Trans; 2006 Jan; (4):617-24. PubMed ID: 16402149
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydrobiopterin rapidly reduces the SOD mimic Mn(III) ortho-tetrakis(N-ethylpyridinium-2-yl)porphyrin.
Batinić-Haberle I; Spasojević I; Fridovich I
Free Radic Biol Med; 2004 Aug; 37(3):367-74. PubMed ID: 15223070
[TBL] [Abstract][Full Text] [Related]
17. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
18. Thermal Stability Kinetics and Shelf Life Estimation of the Redox-Active Therapeutic and Mimic of Superoxide Dismutase Enzyme, Mn(III)
Maia CGC; de Araujo BCR; de Freitas-Marques MB; da Costa IF; Yoshida MI; da Nova Mussel W; Sebastião RCO; Rebouças JS
Oxid Med Cell Longev; 2021; 2021():7003861. PubMed ID: 34912497
[TBL] [Abstract][Full Text] [Related]
19. SOD-like activity of Mn(II) beta-octabromo-meso-tetrakis(N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itself.
DeFreitas-Silva G; Rebouças JS; Spasojević I; Benov L; Idemori YM; Batinić-Haberle I
Arch Biochem Biophys; 2008 Sep; 477(1):105-12. PubMed ID: 18477465
[TBL] [Abstract][Full Text] [Related]
20. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]